Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
💎 5 of the Mag 7 report earnings next week. Which one should you buy?
Ask WarrenAI
Theriva Biologics Inc (TOVX)
Add to/Remove from a Portfolio
Add to Watchlist
0.3450
+0.0030
+0.88%
24/10 - Closed. Currency in USD
After Hours
0.3084
-0.0408
-11.6839%
0:59:47 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 549,590,758
- Bid/Ask: 0.0000 / 0.0000
- Day's Range: 0.3416 - 0.8500
Theriva Biologics
0.3450
+0.0030
+0.88%
- Discussions
- Recent Sentiments
- User Rankings
TOVX User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Theriva Biologics Inc share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | davide garulli | 2 | 2 | 2 | 100 | +100.16% |
| 2 | Jonathan Bishop | 1 | 1 | 1 | 100 | +91.36% |
| 3 | Rostov Angeles | 1 | 1 | 1 | 100 | +90.23% |
| 4 | John Motacek | 1 | 1 | 1 | 100 | +89.75% |
| 5 | Tomer Yaakov | 1 | 1 | 1 | 100 | +89.75% |
| 6 | Antwon Holmes | 1 | 1 | 1 | 100 | +89.56% |
| 7 | Artur Tarabanov | 1 | 1 | 1 | 100 | +86.48% |
| 8 | Brandon Housel | 1 | 1 | 1 | 100 | +86.23% |
| 9 | Mounia Aazari | 1 | 1 | 1 | 100 | +85.37% |
| 10 | Diego Martinez | 1 | 1 | 1 | 100 | +80.92% |
| 11 | Hermann Albrecht | 4 | 4 | 4 | 100 | +75.18% |
| 12 | Robbert Kuipers | 2 | 2 | 2 | 100 | +60.13% |
| 13 | Makik Ibrahim | 1 | 1 | 1 | 100 | +53.45% |
| 14 | Arshad Ali | 1 | 1 | 1 | 100 | +29.51% |
| 15 | Yakkali Bharath | 1 | 1 | 1 | 100 | +29.3% |
| 16 | Kyle Cannell | 1 | 1 | 1 | 100 | +13.46% |
| 17 | Camille Dagenais | 1 | 1 | 1 | 100 | +11.62% |
| 18 | shan he | 1 | 1 | 1 | 100 | +9.92% |
| 19 | Iván Alvarez | 1 | 1 | 1 | 100 | +8.55% |
| 20 | Gandolf Frodovich | 1 | 1 | 1 | 100 | +6.08% |
| 21 | Owen Kent | 1 | 1 | 1 | 100 | +3.26% |
| 22 | Alex Nobili | 1 | 1 | 1 | 100 | +1.96% |
| 23 | Richárd Lengyel | 1 | 1 | 1 | 100 | +1.75% |
| 24 | Sam Charles | 1 | 1 | 1 | 100 | +1.59% |
| 25 | Erki Kallas | 1 | 1 | 1 | 100 | +0.46% |
| 26 | Amir Ansari | 1 | 1 | 0 | 0 | -1.55% |
| 27 | Massimo Giarola | 1 | 1 | 0 | 0 | -1.67% |
| 28 | Allen Young | 3 | 3 | 0 | 0 | -5.61% |
| 29 | valerij andrijchuk | 1 | 1 | 0 | 0 | -9.91% |
| 30 | mohammed murad | 1 | 1 | 0 | 0 | -11.14% |
| 31 | Евгений Захаров | 1 | 1 | 0 | 0 | -12.39% |
| 32 | Antonio Manzanero | 1 | 1 | 0 | 0 | -14.47% |
| 33 | Greg Marte | 1 | 1 | 0 | 0 | -15.17% |
| 34 | Juan P Gomez | 1 | 1 | 0 | 0 | -18.9% |
| 35 | Piotr Gorlicki | 1 | 1 | 0 | 0 | -19.61% |
| 36 | Francisco Herrera | 1 | 1 | 0 | 0 | -20.14% |
| 37 | Spencer Mulligan | 1 | 1 | 0 | 0 | -23.67% |
| 38 | abdulelah alrehili | 1 | 1 | 0 | 0 | -24.02% |
| 39 | Данила Корепанов | 1 | 1 | 0 | 0 | -25.68% |
| 40 | Luke Nemesh | 1 | 1 | 0 | 0 | -27.6% |
| 41 | Keijo K.K | 1 | 1 | 0 | 0 | -28.39% |
| 42 | Mustafa Akçal | 1 | 1 | 0 | 0 | -29% |
| 43 | Will Hernandez | 1 | 1 | 0 | 0 | -29.38% |
| 44 | kunta kinte | 1 | 1 | 0 | 0 | -37.14% |
| 45 | Олег Лаврёнов | 6 | 6 | 4 | 66.67 | -38.27% |
| 46 | Javier Serrano | 1 | 1 | 0 | 0 | -39.71% |
| 47 | Olivier Boulogne | 1 | 1 | 0 | 0 | -64.46% |
| 48 | Jusep Rifà Solsona | 1 | 1 | 0 | 0 | -71.55% |
| 49 | james ha | 1 | 1 | 0 | 0 | -74.28% |
| 50 | Rogelio Jaralba | 1 | 1 | 0 | 0 | -75.93% |
Write your thoughts about Theriva Biologics Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review